Show simple item record

dc.contributor.advisorO'Leary, John
dc.contributor.advisorSheils, Orla
dc.contributor.authorMurphy, Niamh
dc.date.accessioned2019-05-01T13:51:54Z
dc.date.available2019-05-01T13:51:54Z
dc.date.issued2004
dc.identifier.citationNiamh Murphy, 'Molecular markers in cervical cancer', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Histopathology & Morbid Anatomy, 2004, pp 297
dc.identifier.otherTHESIS 7537
dc.identifier.urihttp://hdl.handle.net/2262/86524
dc.description.abstractDespite the introduction of the Papanicolaou (Pap) test carcinoma of the cervix remains one of the most common malignancies amongst women worldwide. It is hoped that the use of HPV testing and molecular biomarkers in conjunction with conventional screening techniques will help to reduce the current high levels of morbidity and mortality associated with cervical screening.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Medicine. Discipline of Histopathology & Morbid Anatomy
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb12393908
dc.subjectHistopathology, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titleMolecular markers in cervical cancer
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 297
dc.description.noteTARA (Trinity's Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record